Inventor

Catherine E. Lofton-Day

Inventor
Seattle, WA, US

Overview

21→
Patents
1997–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 21 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms23%
C07KPeptides21%
A61KPreparations for medical, dental or toiletry purposes17%
G01NInvestigating or analysing materials by determining their chemical or physical properties15%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations9%
C12NMicroorganisms or enzymes4%
H04QSelecting4%
A01KAnimal husbandry2%
C07HSugars2%
Y10TTechnical subjects covered by former us classification2%
PatentTitleYear
10,731,215Method for determining the presence or absence of methylation in a sample202010,385,402Methods and nucleic acids for analyses of cellular proliferative disorders20199,939,441Methods and nucleic acids for analyses for cellular proliferative disorders20189,850,532Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders20179,695,478'Methods and nucleic acids for the analyses of cellular proliferative disorders'20179,605,306'Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders'20178,900,829'Methods and nucleic acids for analyses of cellular proliferative disorders'20148,163,488'Methods and nucleic acids for analysis of colon proliferative disorders'20127,951,563'Methods and nucleic acids for analysis of cellular proliferative disorders'20117,943,308'Methods and nucleic acids for the detection of metastasis of colon cell proliferative disorders'20117,749,702'Methods and nucleic acids for the analyses of cellular proliferative disorders'20107,217,790'UMLR polypeptides'20077,070,774'Antibodies that bind testis-specific insulin homolog polypeptides'20066,709,659'Antibodies that bind testis-specific insulin homolog polypeptides'20046,183,991'Testis-specific insulin homolog polypeptides'20016,046,028'Polynucleotides encoding insulin homolog zins3'20005,989,537'Methods for stimulating granulocyte/macrophage lineage using thrombopoietin'19995,986,049'Purified thrombopoietin and method of making it'19995,959,075'Testis-specific insulin homolog polypeptides'19995,622,843'Phospholipid transfer proteins and DNA encoding them'19975,610,019'Methods of detecting phospholipid transfer activity and kits therefor'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2007Patents assigned to ZYMOGENETICS INC (10)· patent assignee history
1997–2007Based in Brier, WA, US· patent location history
2010–2020Patents assigned to EPIGENOMICS AG (11)· patent assignee history
2010–2020Based in Seattle, WA, US· patent location history
2014–2020Patents assigned to MODEL FABIAN (3)· patent assignee history
2014–2020Patents assigned to SCHUSTER MATTHIAS (3)· patent assignee history
2014–2020Patents assigned to SLEDZIEWSKI ANDREW Z (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
EPIGENOMICS AG112010–2020
ZYMOGENETICS INC101997–2007
MODEL FABIAN32014–2020
SCHUSTER MATTHIAS32014–2020
SLEDZIEWSKI ANDREW Z32014–2020
Locations
LocationPatentsSpan
Seattle, Washington, US112010–2020
Brier, Washington, US101997–2007